Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Documentation of In-Process Control Activities – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Documentation of In-Process Control Activities – V 2.0

Standard Operating Procedure for Documentation of In-Process Control Activities


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/078/2025
Supersedes SOP/SIM/078/2022
Page No. Page 1 of 12
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

To define the procedure for recording and reviewing all in-process control (IPC) activities during sterile injectable product manufacturing in compliance with current Good Manufacturing Practices (cGMP).

2. Scope

This SOP applies to all personnel involved in conducting and documenting IPC tests during batch

processing of sterile injectable products in the manufacturing department.

3. Responsibilities

  • Production Officer: Ensures timely IPC sampling and proper documentation.
  • Quality Control Analyst: Conducts IPC tests and records results.
  • Quality Assurance Officer: Reviews IPC records and ensures compliance.
See also  Quality Assurance: SOP for Documentation of Change Control Processes - V 2.0

4. Accountability

Head – Quality Assurance is accountable for the implementation and periodic review of this SOP and ensuring compliance.

5. Procedure

5.1 Types of In-Process Control Activities

  1. Solution clarity check before filtration
  2. pH and osmolarity of bulk solution
  3. Filter integrity testing
  4. Filling volume verification
  5. Visual inspection of filled units

5.2 Documentation Requirements

  1. Use the approved In-Process Control Logbook (Annexure-1) or controlled batch manufacturing record (BMR) for documentation.
  2. Record the following details immediately after each IPC:
    • Date and time of activity
    • Batch number
    • Test performed
    • Acceptance criteria
    • Observed results
    • Name and signature of analyst
  3. Each entry must be made using indelible ink without overwriting.
See also  Sterile Injectable Manufacturing: SOP for Dispensing Materials for Intraosseous Injections - V 2.0

5.3 Review and Approval

  1. QA shall review and sign IPC records before allowing the next stage of processing.
  2. In case of any out-of-specification or deviation in results, initiate a deviation report as per SOP.

5.4 Record Archival

  1. All IPC records shall be retained as part of the BMR and archived for a minimum of 5 years.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • IPC: In-Process Control
  • BMR: Batch Manufacturing Record
  • QA: Quality Assurance
  • QC: Quality Control

7. Documents

  1. In-Process Control Logbook – Annexure-1
  2. IPC Summary Sheet – Annexure-2
  3. Deviation Report Form – Annexure-3

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • WHO Technical Report Series 961, Annex 6 – GMP Guidelines
  • 21 CFR Part 211 – Current Good Manufacturing Practices

9. SOP Version

Version: 2.0

See also  Sterile Injectable Manufacturing: SOP for Sanitization of Portable Water Systems - V 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: In-Process Control Logbook

Date Batch No. IPC Test Result Acceptable Range Analyst Initials
18/06/2025 INJ-2406 Filling Volume 1.01 mL 1.00 ± 0.05 mL SK

Annexure-2: IPC Summary Sheet

Batch No. Test Result Summary Remarks
INJ-2406 pH 6.8 Within limits

Annexure-3: Deviation Report Form

Deviation ID Date Description Root Cause Corrective Action
DEV-071 17/06/2025 Volume deviation during filling Nozzle obstruction Nozzle cleaned

Revision History

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial version New SOP QA Head
18/06/2025 2.0 Updated IPC tests and annexures Annual Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Elixir Department: SOP for Cleaning Validation of Manufacturing Equipment – V 2.0
Next Post: Analytical Method Development: SOP for Headspace GC Method Development – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version